CN108077935A - Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application - Google Patents
Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application Download PDFInfo
- Publication number
- CN108077935A CN108077935A CN201810059884.6A CN201810059884A CN108077935A CN 108077935 A CN108077935 A CN 108077935A CN 201810059884 A CN201810059884 A CN 201810059884A CN 108077935 A CN108077935 A CN 108077935A
- Authority
- CN
- China
- Prior art keywords
- parts
- aged
- elderly people
- function
- microbial inoculum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 79
- 239000002068 microbial inoculum Substances 0.000 title claims abstract description 68
- 230000036541 health Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000003750 conditioning effect Effects 0.000 claims abstract description 52
- 241000894006 Bacteria Species 0.000 claims abstract description 48
- 240000002605 Lactobacillus helveticus Species 0.000 claims abstract description 36
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 34
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 34
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims abstract description 34
- 229940054346 lactobacillus helveticus Drugs 0.000 claims abstract description 34
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 32
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 32
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 32
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 32
- 229920001202 Inulin Polymers 0.000 claims description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 17
- 229940029339 inulin Drugs 0.000 claims description 17
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 230000000474 nursing effect Effects 0.000 claims description 2
- 206010010774 Constipation Diseases 0.000 abstract description 12
- 206010012735 Diarrhoea Diseases 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000006872 improvement Effects 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 6
- 210000002249 digestive system Anatomy 0.000 abstract description 3
- 230000008944 intestinal immunity Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 20
- 241000723353 Chrysanthemum Species 0.000 description 6
- 235000007516 Chrysanthemum Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000003677 abuse test Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000004880 oxines Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculums and its preparation method and application, are related to function bacterium technical field, and conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum includes following component according to the mass fraction：15 25 parts of bifidobacterium longum, 10 20 parts of Lactobacillus helveticus, 5 10 parts of 5 15 parts of bifidobacterium lactis and rhamnose bacterium, alleviate increase of the middle-aged and elderly people with the age, digestive system declines, intestinal immunity declines, flora imbalance, there is the technical issues of phenomena such as constipation and diarrhea, pass through bifidobacterium longum, Lactobacillus helveticus, bifidobacterium lactis and rhamnose bacterium coordinated, it can be colonized in middle-aged and elderly people's enteron aisle, improve intestinal flora to form, nurse one's health intestinal microecology, phenomena such as prevention and improvement constipation and diarrhea, improve immunity of organisms, promote middle-aged and elderly people's health.
Description
Technical field
The present invention relates to function bacterium technical field, more particularly, to a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum and its system
Preparation Method and application.
Background technology
Live away from home miscellaneous microorganism in the enteron aisle of Healthy People, these microorganisms are known as intestinal flora.Intestinal flora
It combines, depends on each other for existence between each bacterium according to a certain percentage, a kind of ecological balance is formed on quality and quantity.Middle-aged and elderly people is with the age
Increasing, digestive system decline, intestinal immunity declines, and sensitive bacteria is suppressed, and other bacterium amount reproductions cause flora imbalance,
There is phenomena such as constipation, diarrhea, seriously affected the health of middle-aged and elderly people.
In view of this, it is special to propose the present invention.
The content of the invention
One of the objects of the present invention is to provide a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculums., to alleviate middle-aged and elderly people
With the increase at age, digestive system decline, intestinal immunity declines, and the skill of phenomena such as constipation, diarrhea occurs in flora imbalance
Art problem.
Conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum provided by the invention, including following component according to the mass fraction：It is long double
5-10 parts of 15-25 parts of discrimination bacillus, 10-20 parts of Lactobacillus helveticus, 5-15 parts of bifidobacterium lactis and rhamnose bacterium.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, including following component according to the mass fraction：It is long double
5-10 parts of 18-23 parts of discrimination bacillus, 10-15 parts of Lactobacillus helveticus, 8-12 parts of bifidobacterium lactis and rhamnose bacterium.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, including following component according to the mass fraction：It is long double
6-8 parts of 19-22 parts of discrimination bacillus, 12-14 parts of Lactobacillus helveticus, 9-11 parts of bifidobacterium lactis and rhamnose bacterium.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum further includes oligofructose 40- according to the mass fraction
50 parts.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum further includes 1-5 parts of inulin according to the mass fraction.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum also further includes oligofructose according to the mass fraction
42-48 parts and 2-4 parts of inulin.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, viable count are hundred million/g of 100-110.
Further, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, viable count are 10,000,000,000/g.
The second object of the present invention is the preparation method for providing above-mentioned conditioning middle-aged and elderly people function of intestinal canal microbial inoculum, including such as
Lower step：By bifidobacterium longum, Lactobacillus helveticus, bifidobacterium lactis, rhamnose bacterium, optional oligofructose and optional inulin
Be uniformly mixed to get to conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum.
The third object of the present invention is to provide above-mentioned conditioning middle-aged and elderly people function of intestinal canal microbial inoculum in health products, food or medicine
Application in product.
Conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum provided by the invention passes through bifidobacterium longum, Lactobacillus helveticus, newborn bifid
Bacillus and rhamnose bacterium coordinated, can be colonized in middle-aged and elderly people's enteron aisle, improve intestinal flora and form, nurse one's health the micro- life of enteron aisle
Phenomena such as state, prevention and improvement constipation and diarrhea, immunity of organisms is improved, promote middle-aged and elderly people's health.
The preparation method of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum provided by the invention, it is simple for process, it is easy to operate, it is applicable in
In industrialized production.
Specific embodiment
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will
Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the invention.It is not specified in embodiment specific
Condition person, the condition suggested according to normal condition or manufacturer carry out.Reagents or instruments used without specified manufacturer is
The conventional products that can be obtained by commercially available purchase.
According to an aspect of the present invention, the present invention provides a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, including pressing
The following component of mass fraction meter：15-25 parts of bifidobacterium longum, 10-20 parts of Lactobacillus helveticus, 5-15 parts of bifidobacterium lactis and mouse
5-10 parts of Lee sugar bacterium.
Bifidobacterium longum is derived from healthy human body enteron aisle, is checked and approved by U.S.'s food and drug abuse test office, available in food.
Bifidobacterium longum can by inhibit cause of disease and spoilage organisms grow maintain the equilibrium state of human body Tiny ecosystem and enteron aisle, and
With human body intestinal canal is adjusted, improve health efficacy
In the present invention, the typical but non-limiting mass fraction of bifidobacterium longum as 15,15.2,15.5,15.8,
16、16.2、16.5、16.8、17、17.2、17.5、17.8、18、18.2、18.5、18.8、19、19.2、19.5、19.8、20、
20.2、20.5、20.8、21、21.2、21.5、21.8、22、22.2、22.5、22.8、23、23.2、23.5、23.8、24、24.2、
24.5th, 24.8 or 25 parts.
Lactobacillus helveticus is one kind in gram-positive bacterium, and L. helveticus cells surface covers one layer by single
The individual layer lattice structure of protein protomer or glycoprotein composition, can inhibit germ in enteron aisle and infect, improve and pathogen is resisted
Sick power adjusts body immunity and improves the prebiotic effects such as composition of gut flora.Lactobacillus helveticus can also pass through breast of degrading
Albumen generates casein phosphopeptide, promotes absorption of the human body to substances such as calcium, iron, improves the physiological function of bioavailability, together
When can also play the role of enhancing sleep.L. helveticus cells wall peptide glycan can be released by lysozyme hydrolysis with hypnosis
The cell acyl peptide of activity.
In the present invention, the typical but non-limiting mass fraction of Lactobacillus helveticus as 10,10.2,10.5,10.8,
11、11.2、11.5、11.8、12、12.2、12.5、12.8、13、13.2、13.5、13.8、14、14.2、14.5、14.8、15、
15.2、15.5、15.8、16、16.2、16.5、16.8、17、17.2、17.5、17.8、18、18.2、18.518.8、19、19.2、
19.5th, 19.8 or 20 parts.
Bifidobacterium lactis is a kind of physiological bacteria species that can promote our healths, can inhibit pathogen
Growth, prevent constipation and gastrointestinal disorders, and vitamin and amino acid can be synthesized in enteron aisle, improve body to calcium ion
It absorbs, reduces Blood Cholesterol level, prevent hypertension, improve the resistance to lactose of dairy products, improve digestibility, enhance body
Immune technical ability, anti-aging are promoted longevity.
In the present invention, the typical but non-limiting mass fraction of bifidobacterium lactis as 5,5.2,5.5,5.8,6,
6.2nd, 6.5,6.8,7,7.2,7.5,7.8,8,8.2,8.5,8.8,9,9.2,9.5,9.8 or 10 parts.
Rhamnose bacterium is also known as Lactobacillus rhamnosus, is subordinated to lactobacillus, is one of mankind's normal flora, enteron aisle Stickiness
Height, colonization ability is strong, and having efficiently reduces cholesterol, promotes fissional effect, can adjust intestinal flora, prevent and control
Diarrhea and constipation are treated, discharges toxin, improves the important physiological hygiene function such as volume immunity and anticancer.
In the present invention, the typical but non-limiting mass fraction of rhamnose bacterium as 5,5.2,5.5,5.8,6,6.2,
6.5th, 6.8,7,7.2,7.5,7.8,8,8.2,8.5,8.8,9,9.2,9.5,9.8 or 10 parts.
Conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum provided by the invention passes through bifidobacterium longum, Lactobacillus helveticus, newborn bifid
Bacillus and rhamnose bacterium coordinated, can be colonized in middle-aged and elderly people's enteron aisle, improve intestinal flora and form, nurse one's health the micro- life of enteron aisle
Phenomena such as state, prevention and improvement constipation and diarrhea, immunity of organisms is improved, promote middle-aged and elderly people's health.
In the preferred embodiment of the present invention, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is further included by mass fraction
40-50 parts of the oligofructose of meter.
Oligofructose is also known as fructooligosaccharide, is to pass through the fructose in β (2-1) glycosidic bonds and sucrose by 1-3 fructosyl
Base junction symphysis into ketose, Nystose and sugarcane sugar etc. mixture.
Oligofructose is a kind of natural active matter, can be obviously improved microbial population ratio in enteron aisle, is enteral
The activation and proliferation factor of Bifidobacterium, can reduce and inhibit the generation of enteral corrupt substance, inhibit the growth of harmful bacteria, adjust
Enteron aisle inner equilibrium can promote the absorption and utilization of trace elements iron, calcium, to prevent osteoporosis；Hepatotoxin, energy can be reduced
The organic acid of anticancer is generated in intestines, there is significant preventing cancer function.
In the present invention, the typical but non-limiting mass fraction of oligofructose as 40,40.2,40.5,40.8,
41、41.2、41.5、41.8、42、42.2、42.5、42.8、43、43.2、43.5、43.8、44、44.2、44.5、44.8、45、
45.2、45.5、45.8、46、46.2、46.5、46.8、47、47.2、47.5、47.8、48、48.2、48.5、48.8、49、49.2、
49.5th, 49.8 or 50 parts.
In the preferred embodiment of the present invention, conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum further includes 1-5 parts of inulin.
Inulin is deposit property polysaccharide in plant, is mainly derived from plant, inulin molecules about by 31 beta-D-fructofuranoses and
1-2 pyrans synanthrin residue is polymerized, and can pass through β -2,1- key connections between residue of fructose.Inulin can reduce reduction food
In the residence time of stomach and intestine and increase excrement amount, constipation is effectively treated.The wriggling ability of intestines, row can also be enhanced simultaneously
Go out odorous gas, so as to recover the health of intestines.Inulin is also used as bifidobacterium longum, Lactobacillus helveticus, newborn bifid bar simultaneously
Bacterium and the proliferation factor of rhamnose bacterium so as to improve Flora distribution in middle-aged and elderly people's enteron aisle, promote health.
In the present invention, the typical but non-limiting mass fraction of inulin as 1,1.2,1.5,1.8,2,2.2,2.5,
2.8th, 3,3.2,3.5,3.8,4,4.2,4.5,4.8 or 5 parts.
In the preferred embodiment of the present invention, it is 100- to nurse one's health viable count in middle-aged and elderly people's function of intestinal canal microbial inoculum
11000000000/g.
In the typical but nonrestrictive embodiment for being of invention, viable count in middle-aged and elderly people's function of intestinal canal microbial inoculum is nursed one's health
For 100,101,102,103,104,105,106,107,108,109 or 11,000,000,000/g.
In being preferably implemented in embodiment for the present invention, it is 100- to nurse one's health viable count in middle-aged and elderly people's function of intestinal canal microbial inoculum
11000000000/g, i.e. bifidobacterium longum, Lactobacillus helveticus, four kinds of Mixed Microbes of bifidobacterium lactis and rhamnose bacterium for (10-11) ×
1010Cfu/g so as to which assurance function microbial inoculum can be effectively improved intestinal flora composition, nurses one's health intestinal microecology, prevention and improvement are just
Phenomena such as secret and diarrhea, improves immunity of organisms, promotes middle-aged and elderly people's health.
In present invention further optimization embodiment, nurse one's health in middle-aged and elderly people's function of intestinal canal microbial inoculum, viable count 100
Hundred million/g.
It is 10,000,000,000/g when nursing one's health viable count in middle-aged and elderly people's function of intestinal canal microbial inoculum, can more effectively improves middle-aged and elderly people's intestines
Road flora is formed, and more significantly improves immunity of organisms, promotes middle-aged and elderly people's health.
According to the second aspect of the invention, the present invention provides the preparations of above-mentioned conditioning middle-aged and elderly people function of intestinal canal microbial inoculum
Method includes the following steps：By bifidobacterium longum, Lactobacillus helveticus, bifidobacterium lactis, rhamnose bacterium, optional oligofructose
With optional inulin be uniformly mixed to get to conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum.
The preparation method of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum provided by the invention, it is simple for process, it is easy to operate, it is applicable in
In industrialized production.
According to the third aspect of the present invention, the present invention provides above-mentioned conditioning middle-aged and elderly people function of intestinal canal microbial inoculum in health care
Application in product, drug or food.
Technical solution provided by the invention is further described with reference to embodiment and comparative example.
Embodiment 1
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：10 parts of 15 parts of bifidobacterium longum, 20 parts of Lactobacillus helveticus, 5 parts of bifidobacterium lactis and rhamnose bacterium, viable count are 11,000,000,000/g.
Embodiment 2
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：5 parts of 25 parts of bifidobacterium longum, 10 parts of Lactobacillus helveticus, 15 parts of bifidobacterium lactis and rhamnose bacterium, viable count are 10,000,000,000/g.
Embodiment 3
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：40 parts of 18 parts of bifidobacterium longum, 15 parts of Lactobacillus helveticus, 8 parts of bifidobacterium lactis, 10 parts of rhamnose bacterium and oligofructose, it is living
Bacterium number is 10,000,000,000/g.
Embodiment 4
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：50 parts of 23 parts of bifidobacterium longum, 10 parts of Lactobacillus helveticus, 12 parts of bifidobacterium lactis, 5 parts of rhamnose bacterium and oligofructose, it is living
Bacterium number is 10,000,000,000/g.
Embodiment 5
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：19 parts of bifidobacterium longum, 14 parts of Lactobacillus helveticus, 9 parts of bifidobacterium lactis, 8 parts of rhamnose bacterium and 1 part of inulin, viable count are
10000000000/g.
Embodiment 6
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：22 parts of bifidobacterium longum, 12 parts of Lactobacillus helveticus, 11 parts of bifidobacterium lactis, 6 parts of rhamnose bacterium and 5 parts of inulin, viable count are
10000000000/g.
Embodiment 7
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：15 parts of bifidobacterium longum, 20 parts of Lactobacillus helveticus, 5 parts of bifidobacterium lactis, 10 parts of rhamnose bacterium, 45 parts of oligofructose and chrysanthemum
5 parts of powder, viable count are 10,000,000,000/g.
Embodiment 8
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：25 parts of bifidobacterium longum, 10 parts of Lactobacillus helveticus, 15 parts of bifidobacterium lactis, 5 parts of rhamnose bacterium, 44 parts of oligofructose and chrysanthemum
1 part of powder, viable count are 10,000,000,000/g.
Embodiment 9
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：18 parts of bifidobacterium longum, 15 parts of Lactobacillus helveticus, 8 parts of bifidobacterium lactis, 10 parts of rhamnose bacterium, 47 parts of oligofructose and chrysanthemum
2 parts of powder, viable count are 10,000,000,000/g.
Embodiment 10
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：23 parts of bifidobacterium longum, 10 parts of Lactobacillus helveticus, 12 parts of bifidobacterium lactis, 5 parts of rhamnose bacterium, 46 parts of oligofructose and chrysanthemum
4 parts of powder, viable count are 10,000,000,000/g.
Embodiment 11
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：19 parts of bifidobacterium longum, 14 parts of Lactobacillus helveticus, 9 parts of bifidobacterium lactis, 8 parts of rhamnose bacterium, 48 parts of oligofructose and inulin
2 parts, viable count is 10,000,000,000/g.
Embodiment 12
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：22 parts of bifidobacterium longum, 12 parts of Lactobacillus helveticus, 11 parts of bifidobacterium lactis, 6 parts of rhamnose bacterium, 45 parts of oligofructose and chrysanthemum
4 parts of powder, viable count are 10,000,000,000/g.
Embodiment 13
A kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum is present embodiments provided, including according to the mass fraction such as the following group
Point：21 parts of bifidobacterium longum, 13 parts of Lactobacillus helveticus, 10 parts of bifidobacterium lactis, 7 parts of rhamnose bacterium, 46 parts of oligofructose and chrysanthemum
3 parts of powder, viable count are 10,000,000,000/g.
Comparative example 1
This comparative example provide it is a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, this comparative example it is different from embodiment 13 it
It is in not adding in bifidobacterium longum and bifidobacterium lactis.
Comparative example 2
This comparative example provide it is a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, this comparative example it is different from embodiment 13 it
It is in not adding in Switzerland lactic acid bacteria and rhamnose bacterium.
Comparative example 3
This comparative example provide it is a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, this comparative example it is different from embodiment 13 it
It is in not adding in bifidobacterium longum.
Comparative example 4
This comparative example provide it is a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, this comparative example it is different from embodiment 13 it
It is in not adding in Switzerland lactic acid bacteria.
Comparative example 5
This comparative example provide it is a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, this comparative example it is different from embodiment 13 it
It is in not adding in bifidobacterium lactis.
Comparative example 6
This comparative example provide it is a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, this comparative example it is different from embodiment 13 it
It is in not adding in rhamnose bacterium.
Test example
1000 middle-aged and elderly people with diarrhea or constipation are chosen, the age is 50-70 one full year of life, is randomly divided into 20 groups, often
50 people of group are respectively 1-20 groups, wherein 1-13 groups conditioning middle-aged and elderly people's enteron aisle work(that daily embodiment 1-13 is provided respectively
Energy microbial inoculum, 14-19 groups take conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum of comparative example 1-6 offers respectively, and dose is daily
Once, each 1.5g, 20 groups are blank control group, take placebo, after taking 3 months, curative effect statistics are carried out, as a result such as table 1
It is shown.
Table 1 nurses one's health middle-aged and elderly people's function of intestinal canal microbial inoculum curative effect table
The comparison of 1-13 groups and 14-20 groups can be seen that old in conditioning provided by the invention from table 1
Year people's function of intestinal canal microbial inoculum passes through bifidobacterium longum, Lactobacillus helveticus, bifidobacterium lactis and rhamnose bacterium coordinated, Neng Gouding
It plants in middle-aged and elderly people's enteron aisle, improving intestinal flora composition, nurses one's health intestinal microecology, prevention and improvement constipation and diarrhea phenomenon,
Promote middle-aged and elderly people's health.
Can be seen that from the comparison of 7-13 groups and 1-6 groups nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum by bifidobacterium longum,
Lactobacillus helveticus, bifidobacterium lactis, rhamnose bacterium, the coordinated of oligofructose and inulin, can more effectively improve person in middle and old age
People's intestinal flora, more effective conditioning middle-aged and elderly people's stomach Tiny ecosystem is more preferable to the prevention and improvement of constipation and diarrhea, more can
Enough promote middle-aged and elderly people's health.
Finally it should be noted that：The above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations；To the greatest extent
Pipe is described in detail the present invention with reference to foregoing embodiments, it will be understood by those of ordinary skill in the art that：Its according to
Can so modify to the technical solution recorded in foregoing embodiments either to which part or all technical characteristic into
Row equivalent substitution；And these modifications or replacement, the essence of appropriate technical solution is not made to depart from various embodiments of the present invention technology
The scope of scheme.
Claims (10)
1. a kind of conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum, which is characterized in that including following component according to the mass fraction：It is long double
5-10 parts of 15-25 parts of discrimination bacillus, 10-20 parts of Lactobacillus helveticus, 5-15 parts of bifidobacterium lactis and rhamnose bacterium.
2. conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum according to claim 1, which is characterized in that including according to the mass fraction
Following component：18-23 parts of bifidobacterium longum, 10-15 parts of Lactobacillus helveticus, 8-12 parts of bifidobacterium lactis and rhamnose bacterium 5-10
Part.
3. conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum according to claim 1, which is characterized in that including according to the mass fraction
Following component：19-22 parts of bifidobacterium longum, 12-14 parts of Lactobacillus helveticus, 9-11 parts of bifidobacterium lactis and rhamnose bacterium 6-8
Part.
4. according to claim 1-3 any one of them nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum, which is characterized in that further include by
40-50 parts of the oligofructose of mass fraction meter.
5. according to claim 1-3 any one of them nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum, which is characterized in that further include by
1-5 parts of the inulin of mass fraction meter.
6. according to claim 1-3 any one of them nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum, which is characterized in that further include by
2-4 parts of 42-48 parts of the oligofructose of mass fraction meter and inulin.
7. middle-aged and elderly people's function of intestinal canal microbial inoculum is nursed one's health according to claim 1-3 any one of them, which is characterized in that viable count is
Hundred million/g of 100-110.
8. middle-aged and elderly people's function of intestinal canal microbial inoculum is nursed one's health according to claim 1-3 any one of them, which is characterized in that viable count is
10000000000/g.
9. nursing one's health the preparation method of middle-aged and elderly people's function of intestinal canal microbial inoculum according to claim 1-8 any one of them, feature exists
In including the following steps：By bifidobacterium longum, Lactobacillus helveticus, bifidobacterium lactis, rhamnose bacterium, optional oligofructose and
Optional inulin be uniformly mixed to get to conditioning middle-aged and elderly people's function of intestinal canal microbial inoculum.
10. claim 1-8 any one of them nurses one's health middle-aged and elderly people's function of intestinal canal microbial inoculum in health products, food or drug
Using.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810059884.6A CN108077935A (en) | 2018-01-22 | 2018-01-22 | Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810059884.6A CN108077935A (en) | 2018-01-22 | 2018-01-22 | Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108077935A true CN108077935A (en) | 2018-05-29 |
Family
ID=62183360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810059884.6A Pending CN108077935A (en) | 2018-01-22 | 2018-01-22 | Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108077935A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110959792A (en) * | 2018-09-30 | 2020-04-07 | 内蒙古伊利实业集团股份有限公司 | Solid beverage containing bifidobacterium lactis and application thereof |
| CN112042748A (en) * | 2020-09-09 | 2020-12-08 | 甘肃华羚生物技术研究中心有限公司 | Yak milk probiotic powder suitable for middle-aged and elderly people and preparation process thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103648510A (en) * | 2009-05-11 | 2014-03-19 | 雀巢产品技术援助有限公司 | Oral nutritional supplement comprising probiotics |
| CN105962086A (en) * | 2016-05-06 | 2016-09-28 | 广州能靓生物技术有限公司 | Composition and application thereof in preparing health-care product for alleviating stomach discomfort |
| WO2017029245A1 (en) * | 2015-08-14 | 2017-02-23 | Pfeifer & Langen GmbH & Co. KG | Use of allulose as prebiotic |
| CN106615218A (en) * | 2016-12-30 | 2017-05-10 | 北京三元食品股份有限公司 | Yoghurt powder, yoghurt formula powder and production method of yoghurt powder |
| CN106722206A (en) * | 2017-01-09 | 2017-05-31 | 广州能靓生物技术有限公司 | A kind of composition for alleviating alimentary canal malaise symptoms and/or emotional stress and products thereof |
| CN107050062A (en) * | 2016-11-08 | 2017-08-18 | 江西益盟科技有限公司 | Treat lactic bacteria composition of constipation and preparation method thereof |
| CN107242351A (en) * | 2017-06-14 | 2017-10-13 | 南京天益鸿胜生物科技有限公司 | A kind of probiotic composition and its application |
-
2018
- 2018-01-22 CN CN201810059884.6A patent/CN108077935A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103648510A (en) * | 2009-05-11 | 2014-03-19 | 雀巢产品技术援助有限公司 | Oral nutritional supplement comprising probiotics |
| WO2017029245A1 (en) * | 2015-08-14 | 2017-02-23 | Pfeifer & Langen GmbH & Co. KG | Use of allulose as prebiotic |
| CN105962086A (en) * | 2016-05-06 | 2016-09-28 | 广州能靓生物技术有限公司 | Composition and application thereof in preparing health-care product for alleviating stomach discomfort |
| CN107050062A (en) * | 2016-11-08 | 2017-08-18 | 江西益盟科技有限公司 | Treat lactic bacteria composition of constipation and preparation method thereof |
| CN106615218A (en) * | 2016-12-30 | 2017-05-10 | 北京三元食品股份有限公司 | Yoghurt powder, yoghurt formula powder and production method of yoghurt powder |
| CN106722206A (en) * | 2017-01-09 | 2017-05-31 | 广州能靓生物技术有限公司 | A kind of composition for alleviating alimentary canal malaise symptoms and/or emotional stress and products thereof |
| CN107242351A (en) * | 2017-06-14 | 2017-10-13 | 南京天益鸿胜生物科技有限公司 | A kind of probiotic composition and its application |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110959792A (en) * | 2018-09-30 | 2020-04-07 | 内蒙古伊利实业集团股份有限公司 | Solid beverage containing bifidobacterium lactis and application thereof |
| CN112042748A (en) * | 2020-09-09 | 2020-12-08 | 甘肃华羚生物技术研究中心有限公司 | Yak milk probiotic powder suitable for middle-aged and elderly people and preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vaarala | REVIEW Immunological effects of probiotics with special reference to lactobacilli. | |
| Fooks et al. | Probiotics as modulators of the gut flora | |
| JP4623896B2 (en) | Bacterial strains, processed plant extracts and probiotic compositions used in humans and animals | |
| EP4129302A1 (en) | Breast milk oligosaccharides for improving resistance of organism against staphylococcus aureus infection | |
| CN110051003A (en) | A kind of compound probiotic composition and its application | |
| He et al. | Bifidobacterium spp. as functional foods: A review of current status, challenges, and strategies | |
| CN108740251A (en) | A kind of probiotic gel candy and preparation method thereof improving constipation | |
| BRPI0708689A2 (en) | symbiotic mix | |
| CN108770974A (en) | A kind of antianaphylactic probiotic gel candy and preparation method thereof | |
| CN1480528A (en) | Bifidobacterium and products contg same | |
| CN109287920A (en) | A kind of solid beverage and preparation method thereof of multicomponent complex and multi-joint probiotics | |
| CN109430407A (en) | Probiotic combinations preparation | |
| CN108850397A (en) | A kind of probiotic gel candy and preparation method thereof of only diarrhea | |
| CN102524539B (en) | Animal health preserver composition and preparation process for animal health preserver composition | |
| CN111227261A (en) | Prebiotic composition and application thereof | |
| CN109619595A (en) | A kind of composition and its application containing profitable probliotics and prebiotics | |
| CN109315769A (en) | It is a kind of for improving the composition and preparation method thereof of human body enteral environment | |
| CN112438402A (en) | Composite probiotics and preparation method thereof | |
| Mateova et al. | Effect of probiotics, prebiotics and herb oil on performance and metabolic parameters of broiler chickens | |
| CN108077935A (en) | Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application | |
| CN107118981A (en) | A kind of probiotics preparation and its application for being used to nurse one's health enteric microorganism environment | |
| KR20220099914A (en) | Composition for Activating Probiotics through Inhibition of Harmful Bacteria | |
| CN107095308A (en) | A kind of probiotics preparation and its application | |
| CN1121864C (en) | Bifidoquater live bacterial chip | |
| CN108938789A (en) | A kind of more bacterium combination formulations of the adjusting intestinal microecology containing xylo-oligosaccharide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180529 |